Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

被引:75
|
作者
Bunch, T. Jared [1 ]
Munger, Thomas M. [1 ]
Friedman, Paul A. [1 ]
Asirvatham, Samuel J. [1 ]
Brady, Peter A. [1 ]
Cha, Yong-Mei [1 ]
Rea, Robert F. [1 ]
Shen, Win-Kuang [1 ]
Powell, Brian D. [1 ]
Ommen, Steve R. [1 ]
Monahan, Kristi H. [1 ]
Haroldson, Janis M. [1 ]
Packer, Douglas L. [1 ]
机构
[1] St Marys Hosp, Mayo Clin, Heart Rhythm Serv, Dept Internal Med,Div Cardiovasc Dis, Rochester, MN 55902 USA
关键词
catheter ablation; atrial fibrillation; hypertrophic cardiomyopathy; heart atrium; diastole;
D O I
10.1111/j.1540-8167.2008.01192.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Substrate and Procedural Predictors of Outcome in Patients with Hypertrophic Cardiomyopathy. Background: Hypertrophic cardiomyopathy (HCM) is often accompanied by atrial fibrillation (AF) due to diastolic dysfunction, elevated left atrial pressure, and enlargement. Although catheter ablation for drug-refractory AF is an effective treatment, the efficacy in HCM remains to be established. Methods: Thirty-three consecutive patients (25 male, age 51 +/- 11 years) with HCM underwent pulmonary vein (PV) isolation (n = 8) or wide area circumferential ablation with additional linear ablation (n = 25) for drug-refractory AF. Twelve-lead and 24-hour ambulating ECGs, echocardiograms, event monitor strips, and SF 36 quality of life (QOL) surveys were obtained before ablation and for routine follow-up. Results: Twenty-one (64%) patients had paroxysmal AF and 12 (36%) had persistent/permanent AF for 6.2 +/- 5.2 years. The average ejection fraction was 0.63 +/- 0.12. The average left atrial volume index was 70 +/- 24 mL/m(2). Over a follow-up of 1.5 +/- 1.2 years, 1-year survival with AF elimination was 62%(Confidence Interval [CI]: 66-84) and with AF control was 75%(CI: 66-84). AF control was less likely in patients with a persistent/chronic AF, larger left atrial volumes, and more advanced diastolic disease. Additional linear ablation may improve outcomes in patient with severe left atrial enlargement and more advanced diastolic dysfunction. Two patients had a periprocedureal TIA, one PV stenosis, and one died after mitral valve replacement from prosthetic valve thrombosis. QOL scores improved from baseline at 3 and 12 months. Conclusion: Outcomes after AF ablation in patients with HCM are favorable. Diastolic dysfunction, left atrial enlargement, and AF subtype influence outcomes. Future studies of rhythm management approaches in HCM patients are required to clarify the optimal clinical approach.
引用
收藏
页码:1009 / 1014
页数:6
相关论文
共 50 条
  • [21] Long-term clinical course after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
    Higuchi, Satoshi
    Ejima, Koichiro
    Minami, Yuichiro
    Ooyabu, Kenjiro
    Iwanami, Yuji
    Yagishita, Daigo
    Shoda, Morio
    Hagiwara, Nobuhisa
    HEART AND VESSELS, 2019, 34 (03) : 527 - 537
  • [22] Long-term clinical course after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
    Satoshi Higuchi
    Koichiro Ejima
    Yuichiro Minami
    Kenjiro Ooyabu
    Yuji Iwanami
    Daigo Yagishita
    Morio Shoda
    Nobuhisa Hagiwara
    Heart and Vessels, 2019, 34 : 527 - 537
  • [23] Drastically decrease of left atrial pressure in patients with hypertrophic cardiomyopathy by catheter ablation for atrial fibrillation
    Ikenaga, H.
    Nakano, Y.
    Oda, N.
    Sairaku, A.
    Kajihara, K.
    Tokuyama, T.
    Fujiwara, M.
    Kawazoe, H.
    Watanabe, Y.
    Kihara, Y.
    EUROPEAN HEART JOURNAL, 2014, 35 : 431 - 431
  • [24] Left Atrial Wall Thickness in Patients With Hypertrophic Cardiomyopathy Undergoing Catheter Ablation for Atrial Fibrillation
    Hayashi, Hiroshi
    Hayashi, Meiso
    Miyauchi, Yasushi
    Takahashi, Kenta
    Tsuboi, Ippei
    Uetake, Shunsuke
    Murata, Hiroshige
    Yodogawa, Kenji
    Iwasaki, Yu-ki
    Shimizu, Wataru
    CIRCULATION, 2013, 128 (22)
  • [25] Procedural Outcomes of Patients With Heart Failure Undergoing Catheter Ablation of Atrial Fibrillation
    Jayanna, Manju Bengaluru
    Mohsen, Ala
    Inampudi, Chakradhari
    Alvarez, Paulino
    Giudici, Michael C.
    Briasoulis, Alexandros
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (03) : E333 - E338
  • [26] Protective Effect of Catheter Ablation of Atrial Fibrillation on the Renal Function in Patients With Hypertrophic Cardiomyopathy
    Mimuro, Rei
    Hayashi, Hiroshi
    Iwasaki, Yu-ki
    Hachisuka, Masato
    Fujimoto, Yuhi
    Oka, Eiichiro
    Murata, Hiroshige
    Yamamoto, Teppei
    Yodogawa, Kenji
    Shimizu, Wataru
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 173 : 8 - 15
  • [27] Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study
    Creta, Antonio
    Elliott, Perry
    Earley, Mark J.
    Dhinoja, Mehul
    Finlay, Malcolm
    Sporton, Simon
    Chow, Anthony
    Hunter, Ross J.
    Papageorgiou, Nikolaos
    Lowe, Martin
    Mohiddin, Saidi A.
    Boveda, Serge
    Adragao, Pedro
    Jebberi, Zeynab
    Matos, Daniel
    Schilling, Richard J.
    Lambiase, Pier D.
    Providencia, Rui
    EUROPACE, 2021, 23 (09): : 1409 - 1417
  • [28] OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION IN HYPERTROPHIC CARDIOMYOPATHY: A PROPENSITY-MATCHED NATIONAL STUDY
    Ali, Shafaqat
    Kumar, Manoj
    Alsaeed, Thannon
    Duhan, Sanchit
    Ponna, Pramod Kumar
    Farooq, Faryal
    Keisham, Bijeta
    Ahmad, Muhammad
    Modi, Malak
    Thotamgari, Sahith Reddy
    Younas, Hafiz Muhammad Waqar
    Talpur, Abdul Subhan
    Abdul, Karim Amidou
    Sattar, Yasar
    Surapaneni, Phani
    Helmy, Tarek
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 146 - 146
  • [29] Effect of catheter ablation vs medical therapy on cardiovascular outcomes in hypertrophic cardiomyopathy with atrial fibrillation
    Kim, D.
    Yang, P-S
    Jang, E.
    Yu, H-T
    Kim, T-H
    Uhm, J-S
    Pak, H-N
    Lee, M-H
    Sung, J-H
    Joung, B.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [30] Atrial Substrate Underlies the Recurrence after Catheter Ablation in Patients with Atrial Fibrillation
    Baek, Yong-Soo
    Choi, Jong-Il
    Kim, Yun Gi
    Lee, Kwang-No
    Roh, Seung-Young
    Ahn, Jinhee
    Kim, Dong-Hyeok
    Lee, Dae In
    Hwang, Sung Ho
    Shim, Jaemin
    Kim, Jin Seok
    Kim, Dae-Hyeok
    Park, Sang-Weon
    Kim, Young-Hoon
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 13